PALMOPLANTAR PUSTULOSIS (PPP)
Clinical trials for PALMOPLANTAR PUSTULOSIS (PPP) explained in plain language.
Never miss a new study
Get alerted when new PALMOPLANTAR PUSTULOSIS (PPP) trials appear
Sign up with your email to follow new studies for PALMOPLANTAR PUSTULOSIS (PPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for painful hand and foot skin disease: experimental drug enters trial
Disease control Recruiting nowThis study tests a new biologic drug called Xeligekimab in 10 adults with moderate to severe palmoplantar pustulosis (PPP), a chronic skin disease causing painful blisters and scales on the palms and soles. The goal is to see if the drug can reduce symptoms and improve quality of…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: PHASE4 • Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New pill hopes to clear stubborn hand and foot blisters
Disease control Recruiting nowThis study tests a daily pill called ivarmacitinib for palmoplantar pustulosis (PPP), a chronic skin condition causing painful blisters on hands and feet. Sixty adults who haven't improved with other treatments will take the pill for 12 weeks. Researchers will check if symptoms l…
Matched conditions: PALMOPLANTAR PUSTULOSIS (PPP)
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC